SLEEPNeurosciencePeer-reviewed journal article
The Development of Sleep/Wake Disruption and Cataplexy as Hypocretin/Orexin Neurons Degenerate in Male vs. Female Orexin/tTA; TetO-DTA Mice
Yu SuniD, Ryan K. TisdaleiD, Sunmee ParkiD, Shun‐Chieh MaiD, Jasmine HeuiD, Meghan HaireiD, Giancarlo AlloccaiD, Akihiro YamanakaiD, Stephen R. MorairtyiD, Thomas S. KilduffiD
Abstract
Narcolepsy Type 1 (NT1), a sleep disorder with similar prevalence in both sexes, is thought to be due to loss of the hypocretin/orexin (Hcrt) neurons. Several transgenic strains have been created to model this disorder and are increasingly being used for preclinical drug development and basic science studies, yet most studies have solely used male mice. We compared the development of narcoleptic symptomatology in male vs. female orexin-tTA; TetO-DTA mice, a model in which Hcrt neuron degeneration can be initiated by removal of doxycycline (DOX) from the diet. EEG, EMG, body temperature, gross motor activity and video recordings were conducted for 24-h at baseline and 1, 2, 4 and 6 weeks after DOX removal. Female DTA mice exhibited cataplexy, the pathognomonic symptom of NT1, by Week 1 in the DOX(-) condition but cataplexy was not consistently present in males until Week 2. By Week 2, both sexes showed an impaired ability to sustain long wake bouts during the active period, the murine equivalent of excessive daytime sleepiness in NT1. Body temperature appeared to be regulated at lower levels in both sexes as the Hcrt neurons degenerated. During degeneration, both sexes also exhibited the "Delta State", characterized by sudden cessation of activity, high delta activity in the EEG, maintenance of muscle tone and posture, and the absence of phasic EMG activity. Since the phenotypes of the two sexes were indistinguishable by Week 6, we conclude that both sexes can be safely combined in future studies to reduce cost and animal use. Statement of SignificanceAlthough narcolepsy is a disorder that affects both men and women with similar frequency, most basic research and preclinical development studies of sleep have utilized male experimental subjects. The identification of the hypocretin/orexin (Hcrt) neuron loss as the likely cause of human narcolepsy has led to the development of transgenic mouse strains that model this disorder. Here, we compare the emergence of narcoleptic symptoms in male vs. female bigenic orexin-tTA; TetO DTA mice, a state-of-the-art narcolepsy model in which degeneration of the Hcrt neurons can be triggered by dietary manipulation. We find that female mice develop the narcoleptic phenotype more rapidly than males but that both sexes are equally symptomatic by the end of the degeneration period.
- Citations
- 22
- FWCI
- 2.32
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Partial ablation of the orexin field induces a sub narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration
Sarah W. Wurts, Jessica D. Sun, … Paul S. Humphries·SLEEPPeer-reviewed·May 31, 2018
- Evaluation of the Efficacy of the Hypocretin/orexin Receptor Agonists TAK-925 and ARN-776 in Narcoleptic Orexin/tTA; TetO-DTA Mice
Yu Sun, Alok Ranjan, … Thomas S. Kilduff·bioRxiv·Dec 9, 2022
- Peripheral vs. Core Body Temperature as Hypocretin/Orexin Neurons Degenerate: Exercise Mitigates Increased Heat Loss
Yu Sun, Ryan K. Tisdale, … Thomas S. Kilduff·PeptidesPeer-reviewed·Jun 1, 2023
- Dual Orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy
Chi Jung Hung, Daisuke Ono, … Akihiro Yamanaka·eLifePeer-reviewed·Apr 17, 2020
- Narcolepsy and the Dissociation of REM Sleep and Cataplexy through Ambient Temperature Manipulation
Bianca Viberti, Lisa Branca, … Markus Helmut Schmidt·bioRxiv·Dec 29, 2021
- Partial lesions of hypocretin neurons of the rat lateral hypothalamus affect wake and sleep regulation under increased sleep pressure
Maria Lebedeva, David Levčík, … Aleš Stuchlı́k·bioRxiv·Oct 24, 2026